2022 CAR 指南:对比剂相关急性肾损伤

2022-05-24 加拿大放射科医师协会 Canadian Journal of Kidney Health and Disease

碘化造影剂是最常用的药物之一。在加拿大,2019 年进行了超过 540 万次计算机断层扫描 (CT) 检查,其中 50% 进行了对比增强。碘对比剂给药后发生的急性肾损伤 (AKI) 历来被认为是一种常

中文标题:

2022 CAR 指南:对比剂相关急性肾损伤

英文标题:

Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury

发布日期:

2022-05-24

简要介绍:

碘化造影剂是最常用的药物之一。在加拿大,2019 年进行了超过 540 万次计算机断层扫描 (CT) 检查,其中 50% 进行了对比增强。碘对比剂给药后发生的急性肾损伤 (AKI) 历来被认为是一种常见的医源性并发症,可通过筛查患者、预防策略和肾功能随访评估来管理。加拿大放射科医师协会 (CAR) 最初于 2007 年发布了预防造影剂肾病的指南,并于 2012 年进行了更新。然而,该领域的新发展导致更安全的造影剂的可用性和临床实践的变化,促使对早期建议的完整修订。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 CAR 指南:对比剂相关急性肾损伤.pdf)] GetToolGuiderByIdResponse(projectId=1, id=41d7a1c0025585e7, title=2022 CAR 指南:对比剂相关急性肾损伤, enTitle=Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury, guiderFrom=Canadian Journal of Kidney Health and Disease, authorId=0, author=, summary=碘化造影剂是最常用的药物之一。在加拿大,2019 年进行了超过 540 万次计算机断层扫描 (CT) 检查,其中 50% 进行了对比增强。碘对比剂给药后发生的急性肾损伤 (AKI) 历来被认为是一种常, cover=https://img.medsci.cn/20220802/1659425709728_1608702.jpg, journalId=0, articlesId=null, associationId=1009, associationName=加拿大放射科医师协会, associationIntro=null, copyright=0, guiderPublishedTime=Tue May 24 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #545454;">碘化造影剂是最常用的药物之一。</span><span style="color: #545454;">在加拿大,2019 年进行了超过 540 万次计算机断层扫描 (CT) 检查,其中 50% 进行了对比增强。</span><span style="color: #545454;">碘对比剂给药后发生的急性肾损伤 (AKI) 历来被认为是一种常见的医源性并发症,可通过筛查患者、预防策略和肾功能随访评估来管理。</span><span style="color: #545454;">加拿大放射科医师协会 (CAR) 最初于 2007 年发布了预防造影剂肾病的指南,并于 2012 年进行了更新。然而,该领域的新发展导致更安全的造影剂的可用性和临床实践的变化,促使对早期建议的完整修订。</span></p>, tagList=[TagDto(tagId=457752, tagName=对比剂相关急性肾损伤)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=6, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5148, appHits=87, showAppHits=0, pcHits=511, showPcHits=5057, likes=0, shares=15, comments=5, approvalStatus=1, publishedTime=Sat Aug 06 15:31:00 CST 2022, publishedTimeString=2022-05-24, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Tue Aug 02 15:37:14 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 15:58:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 CAR 指南:对比剂相关急性肾损伤.pdf)])
2022 CAR 指南:对比剂相关急性肾损伤.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241618, encodeId=a7e912416181c, content=<a href='/topic/show?id=739746640f3' target=_blank style='color:#2F92EE;'>#对比剂#</a>相关<a href='/topic/show?id=7cd15239687' target=_blank style='color:#2F92EE;'>#急性肾损伤#</a><a href='/topic/show?id=079682559a1' target=_blank style='color:#2F92EE;'>#肾损伤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46640, encryptionId=739746640f3, topicName=对比剂), TopicDto(id=52396, encryptionId=7cd15239687, topicName=急性肾损伤), TopicDto(id=82559, encryptionId=079682559a1, topicName=肾损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:27:17 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237300, encodeId=64d0123e300e7, content=好文,学习了😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:38 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237299, encodeId=da7e123e29939, content=😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:18 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1241618, encodeId=a7e912416181c, content=<a href='/topic/show?id=739746640f3' target=_blank style='color:#2F92EE;'>#对比剂#</a>相关<a href='/topic/show?id=7cd15239687' target=_blank style='color:#2F92EE;'>#急性肾损伤#</a><a href='/topic/show?id=079682559a1' target=_blank style='color:#2F92EE;'>#肾损伤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46640, encryptionId=739746640f3, topicName=对比剂), TopicDto(id=52396, encryptionId=7cd15239687, topicName=急性肾损伤), TopicDto(id=82559, encryptionId=079682559a1, topicName=肾损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:27:17 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237300, encodeId=64d0123e300e7, content=好文,学习了😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:38 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237299, encodeId=da7e123e29939, content=😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:18 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2022-08-08 ms1000000590489287

    好文,学习了😃

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241618, encodeId=a7e912416181c, content=<a href='/topic/show?id=739746640f3' target=_blank style='color:#2F92EE;'>#对比剂#</a>相关<a href='/topic/show?id=7cd15239687' target=_blank style='color:#2F92EE;'>#急性肾损伤#</a><a href='/topic/show?id=079682559a1' target=_blank style='color:#2F92EE;'>#肾损伤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46640, encryptionId=739746640f3, topicName=对比剂), TopicDto(id=52396, encryptionId=7cd15239687, topicName=急性肾损伤), TopicDto(id=82559, encryptionId=079682559a1, topicName=肾损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:27:17 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237300, encodeId=64d0123e300e7, content=好文,学习了😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:38 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237299, encodeId=da7e123e29939, content=😃, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8af68230250, createdName=ms1000000590489287, createdTime=Mon Aug 08 11:41:18 CST 2022, time=2022-08-08, status=1, ipAttribution=)]
    2022-08-08 ms1000000590489287

    😃

    0